Merilog will be provided by prefilled pen in a 3 mL dose or ... its insulins by 70%. Less than two weeks later, Novo Nordisk announced a planned 75% reduction in the cost of NovoLog.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback